Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masaaki Inaba

Showing results (51-60 of 430) with videos related to

Pageof 43
Sort By:
Advances in Clinical Chemistry|March 9, 2012
Fetuin-A and the cardiovascular systemKatsuhito Mori, Masanori Emoto, Masaaki Inaba
Diabetes Care|March 22, 2014
Response to comment on Tsuda et al. Poor glycemic control is a major factor in the overestimation of glomerular filtration rate in diabetic patients. Diabetes care 2014;37:596-603Akihiro Tsuda, Eiji Ishimura, Masaaki Inaba
Clinical Calcium|March 19, 2005
[Renal osteodystrophy with diabetic bone disease]Yasuro Kumeda, Masaaki Inaba, Eiji Ishimura
Clinical Calcium|December 4, 2004
[Metabolic bone disease and bone quality]Shinsuke Yamada, Masaaki Inaba, Yoshiki Nishizawa
Annals of Nuclear Medicine|February 1, 2006
Sentinel lymphoscintigraphy in patients with breast cancer undergoing excisional biopsyEiji Ohtake, Taro Asaga, Masaaki Inaba
Expert Opinion on Drug Discovery|March 16, 2013
Animal models of hyperfunctioning parathyroid diseases for drug developmentYasuo Imanishi, Masaaki Inaba, Takehisa Kawata, et al.
Journal of Renal Nutrition : the Official Journal of the Council on Renal Nutrition of the National Kidney Foundation|January 6, 2015
Endocrine and metabolic changes affecting cardiovascular disease in dialysis patientsTetsuo Shoji, Masanori Emoto, Yoshiki Nishizawa, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|September 22, 2009
Cinacalcet in hyperfunctioning parathyroid diseasesYasuo Imanishi, Masaaki Inaba, Takehisa Kawata, et al.
Kidney International|June 6, 2008
Bone formation by minimodeling is more active than remodeling after parathyroidectomyAiji Yajima, Masaaki Inaba, Yoshihiro Tominaga, et al.
BMJ Open Diabetes Research & Care|August 23, 2016
Linagliptin monotherapy compared with voglibose monotherapy in patients with type 2 diabetes undergoing hemodialysis: a 12-week randomized trialKatsuhito Mori, Masanori Emoto, Tetsuo Shoji, et al.
Pageof 43

Showing results (51-60 of 430) with videos related to

Sort By:
Pageof 43
Advances in Clinical Chemistry|March 9, 2012
Fetuin-A and the cardiovascular systemKatsuhito Mori, Masanori Emoto, Masaaki Inaba
Diabetes Care|March 22, 2014
Response to comment on Tsuda et al. Poor glycemic control is a major factor in the overestimation of glomerular filtration rate in diabetic patients. Diabetes care 2014;37:596-603Akihiro Tsuda, Eiji Ishimura, Masaaki Inaba
Clinical Calcium|March 19, 2005
[Renal osteodystrophy with diabetic bone disease]Yasuro Kumeda, Masaaki Inaba, Eiji Ishimura
Clinical Calcium|December 4, 2004
[Metabolic bone disease and bone quality]Shinsuke Yamada, Masaaki Inaba, Yoshiki Nishizawa
Annals of Nuclear Medicine|February 1, 2006
Sentinel lymphoscintigraphy in patients with breast cancer undergoing excisional biopsyEiji Ohtake, Taro Asaga, Masaaki Inaba
Expert Opinion on Drug Discovery|March 16, 2013
Animal models of hyperfunctioning parathyroid diseases for drug developmentYasuo Imanishi, Masaaki Inaba, Takehisa Kawata, et al.
Journal of Renal Nutrition : the Official Journal of the Council on Renal Nutrition of the National Kidney Foundation|January 6, 2015
Endocrine and metabolic changes affecting cardiovascular disease in dialysis patientsTetsuo Shoji, Masanori Emoto, Yoshiki Nishizawa, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|September 22, 2009
Cinacalcet in hyperfunctioning parathyroid diseasesYasuo Imanishi, Masaaki Inaba, Takehisa Kawata, et al.
Kidney International|June 6, 2008
Bone formation by minimodeling is more active than remodeling after parathyroidectomyAiji Yajima, Masaaki Inaba, Yoshihiro Tominaga, et al.
BMJ Open Diabetes Research & Care|August 23, 2016
Linagliptin monotherapy compared with voglibose monotherapy in patients with type 2 diabetes undergoing hemodialysis: a 12-week randomized trialKatsuhito Mori, Masanori Emoto, Tetsuo Shoji, et al.
Pageof 43